Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

allergan

Allergan appoints ex-Abbott exec in “Board refreshment” move

June 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Allergan, appointment, pharma

Allergan has announced another move in its “refreshment” of its executive Board of Directors with the appointment of Thomas C …
News

Living with childhood dementia

June 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing childhood dementia, dementia, feature, patient experience, pharma

Claire Young explores her family’s journey through the diagnosis of her son George, who lives with Batten disease, a form …
Feature
brexit

Brexit negotiations: Is the public’s health a priority?

June 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical

The Brexit decision has created a huge amount of question marks for many industries and each is vying with each …
Feature
dna-1903319_960_720

Research casts doubts over CRISPR safety

June 12, 2018 Manufacturing and Production, Research and Development biotech, crispr, drugs, pharma, pharmaceutical

Research emerging from two studies, published in same issue of Nature, has raised significant questions over just how safe CRISPR …
News
shutterstock_339308225

Vical terminates genital herpes vaccine after trial failure

June 12, 2018 Manufacturing and Production, Research and Development Vaccine, Vical, herpes, pharma

San Diego-based biopharma firm Vical has announced the disappointing, if unsurprising, news that it has taken the decision to terminate …
News
allergan

Allergan’s atogepant fulfils primary endpoint in episodic migraine

June 12, 2018 Manufacturing and Production, Research and Development Allergan, atogepant, migraine, pharma

Allergan has made ground in its quest to become “the headache company” with the release of new Phase 2b/3 data …
News
nerve-cell-2213009_960_720

Another failure in Alzheimer’s creates bleak outlook for treatment

June 12, 2018 Manufacturing and Production, Research and Development Alzheimer's, AstraZeneca, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Finding a treatment for Alzheimer’s disease has been one of the aims of big pharma for last few decades, but …
News
handshake_2

Alexion goes back to roots with Complement deal

June 11, 2018 Manufacturing and Production, Sales and Marketing Alexion, biotech, drugs, pharma, pharmaceutical, soliris

Alexion has made a lot of money from investing in the science behind complement inhibitors – C5 inhibitor, Soliris, has …
News
top_ten

Top Ten most popular articles on Pharmafile.com this week

June 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

With ASCO occurring over the weekend, the headlines this week have been dominated by the news of breaking research that …
News
nerves

Parkinson’s disease: A quest for steadier therapies

June 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Parkinson's disease, biotech, drugs, pharma, pharmaceutical

The worrying number of deaths associated with Nuplazid has eyes returning to the pipeline for Parkinson’s disease. Anjali Shukla, a …
Feature

FlyPharma Conference Europe concludes its fourth successful year in Brussels

June 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, flypharma, pharma, pharmaceutical

The FlyPharma Conference Europe wrapped up for another year on 6 June, returning with an expanded roster of speakers who …
News
bill_hinshaw

Novartis’ US Oncology head makes leap to become biotech CEO

June 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis

The departure of high-level, big pharma executives to tiny biotechs is steadily becoming a constant stream; the latest is Bill …
Appointment
david_elkins

Celgene bring in new CFO to steady the ship

June 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene

The fact that Celgene is currently sailing through choppy waters is no secret to anyone within the industry, it’s facing …
Appointment
shutterstock_273326141

Axovant snatches Teva and Allergan execs to strengthen management

June 5, 2018 Manufacturing and Production, Medical Communications Allergan, Axovant, Teva, appointment, pharma

Axovant has announced reinforcements to its management team with two new additions, snatching up Allergan’s current Chief Medical Officer Dr …
News
lilly_building_with_american_flag_web

FDA greenlights Lilly’s Olumiant in rheumatoid arthritis, with major caveats

June 5, 2018 Manufacturing and Production, Sales and Marketing Eli Lilly, FDA, Olumiant, pharma

Eli Lilly has announced that its oral JAK inhibitor Olumiant (baricitinib) has received FDA approval for the treatment of moderately-to-severely …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026